Figure 1.
Demographic and clinical characteristics of study participants
| CHARACTERISTICS | NUMBER (%) |
|---|---|
| Median age (years) | 29 |
| Born before 1991 (N) | 18 |
| Haemophilia type | |
| Haemophilia A | 59 (89.4%) |
| Haemophilia B | 7 (10.6%) |
| Haemophilia severity | |
| Mild | 2 (3.03%) |
| Severe | 64 (96.9%) |
| Inhibitor status | |
| Positive | 10 (15.1%) |
| Negative | 56 (84.8%) |
| Haemophilia Centre | |
| SBAH | 23 (34.9%) |
| DGMAH | 7 (10.6%) |
| CMJAH | 36 (54.6%) |
Serology results of study participants
| SEROMARKERS | POSITIVE/NEGATIVE | NUMBER (%) |
|---|---|---|
| HIV | Positive | 5 (7.6%) |
| Negative | 61 (95.3%) | |
| Anti-HCV IgG | Positive | 0 |
| Negative | 66 (100%) | |
| Anti-HBc total | Positive | 5 (7.6%) |
| Negative | 61 (95.3%) | |
| Anti-HBs | Positive | 56 (84.8%) |
| Negative | 10 (15.1%) | |